Full Text View
Tabular View
No Study Results Posted
Related Studies
Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)
This study is ongoing, but not recruiting participants.
Study NCT01390922   Information provided by GlaxoSmithKline

First Received on July 7, 2011.   Last Updated on June 6, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mumps
Additional conditions recognized in this trial
Muscle Spasticity
More general conditions related to this trial
Mononegavirales Infections
Mouth Diseases
Muscle Hypertonia
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Manifestations
Paramyxoviridae Infections
Parotid Diseases
Parotitis
RNA Virus Infections
Rubulavirus Infections
Salivary Gland Diseases
Signs and Symptoms
Stomatognathic Diseases
Virus Diseases
Interventions listed in this trial
Botulinum Toxin Type A
Additional drug interventions recognized in this trial
Botulinum Toxins
Botulinum Toxins, Type A
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Central Nervous System Agents
Neuromuscular Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services